These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30474240)

  • 1. Adjusting for selection bias in assessing treatment effect estimates from multiple subgroups.
    Glimm E
    Biom J; 2019 Jan; 61(1):216-229. PubMed ID: 30474240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sharp simultaneous confidence intervals for the means of selected populations with application to microarray data analysis.
    Qiu J; Hwang JT
    Biometrics; 2007 Sep; 63(3):767-76. PubMed ID: 17403105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model averaging for treatment effect estimation in subgroups.
    Bornkamp B; Ohlssen D; Magnusson BP; Schmidli H
    Pharm Stat; 2017 Mar; 16(2):133-142. PubMed ID: 27935199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of treatment effect in a subpopulation: An empirical Bayes approach.
    Shen C; Li X; Jeong J
    J Biopharm Stat; 2016; 26(3):507-18. PubMed ID: 26010422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting potential safety issues in clinical trials by Bayesian screening.
    Gould AL
    Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes.
    Chen N; Lee JJ
    Biom J; 2019 Sep; 61(5):1219-1231. PubMed ID: 30506747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation issues in clinical trials and overviews.
    Pocock SJ; Hughes MD
    Stat Med; 1990 Jun; 9(6):657-71. PubMed ID: 2145623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical considerations for using functional uniform prior distributions for dose-response estimation in clinical trials.
    Bornkamp B
    Biom J; 2014 Nov; 56(6):947-62. PubMed ID: 24984691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On estimation of vaccine efficacy using validation samples with selection bias.
    Scharfstein DO; Halloran ME; Chu H; Daniels MJ
    Biostatistics; 2006 Oct; 7(4):615-29. PubMed ID: 16556610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure detection of semiparametric structural equation models with Bayesian adaptive group lasso.
    Feng XN; Wang GC; Wang YF; Song XY
    Stat Med; 2015 Apr; 34(9):1527-47. PubMed ID: 25640461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian effect estimation accounting for adjustment uncertainty.
    Wang C; Parmigiani G; Dominici F
    Biometrics; 2012 Sep; 68(3):661-71. PubMed ID: 22364439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A general framework for constraint approaches to adjusted risk differences.
    Tang Y; Xia M; Sun L; Spertus JA; Jones PG
    Biom J; 2018 Jan; 60(1):207-215. PubMed ID: 29110320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models.
    Fang Q; Piegorsch WW; Simmons SJ; Li X; Chen C; Wang Y
    Biometrics; 2015 Dec; 71(4):1168-75. PubMed ID: 26102570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else.
    Varadhan R; Wang SJ
    Biom J; 2016 Jan; 58(1):133-53. PubMed ID: 26485117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian approach to finite mixture models in bioassay via data augmentation and Gibbs sampling and its application to-insecticide resistance.
    Qu P; Qu Y
    Biometrics; 2000 Dec; 56(4):1249-55. PubMed ID: 11129487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials.
    Du Y; Li J; Raha S; Qu Y
    Stat Med; 2024 Jul; 43(15):2928-2943. PubMed ID: 38742595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation in Bayesian disease mapping.
    MacNab YC; Farrell PJ; Gustafson P; Wen S
    Biometrics; 2004 Dec; 60(4):865-73. PubMed ID: 15606406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
    Waddingham E; Mt-Isa S; Nixon R; Ashby D
    Biom J; 2016 Jan; 58(1):28-42. PubMed ID: 25631038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical Bayes estimation of hunting success rates with spatial correlations.
    He Z; Sun D
    Biometrics; 2000 Jun; 56(2):360-7. PubMed ID: 10877290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.